Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma. Iorgulescu JB, Gokhale PC, Speranza MC, Eschle BK, et al. Clin Cancer Res 2020 Nov 25. pii: 1078-0432.CCR-20-2291.

Read + Share

Amedeo Smart

Independent Medical Education

Iorgulescu JB, Gokhale PC, Speranza MC, Eschle BK, et al. Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma. Clin Cancer Res 2020 Nov 25. pii: 1078-0432.CCR-20-2291.
PMID: 33239433